Italy · Research startup
Italy · Contraria Biotech
Contraria Biotech (formerly AchilleS Vaccines) is a biopharmaceutical development company that aims to create sustainable therapeutic and prophylactic drugs against infectious diseases.
Funding reportedLast round: Seed
Follow Contraria Biotech and see its new rounds in your feed.Start following
About Contraria Biotech
Contraria Biotech (formerly AchilleS Vaccines) is a biopharmaceutical development company that aims to create sustainable therapeutic and prophylactic drugs against infectious diseases.
We are committed to designing innovative, cost-effective therapeutic and prophylactic products to address some of today's major global health problems, including antibiotic resistance, emerging diseases and pandemics.
What company datasets say Contraria Biotech raised
Funding, as reported
The company, in detail
What they build
Known for
biotechnology research
Built with from their website
ArubaMicrosoft Exchange OnlineApple Business ManagerMicrosoft ExchangeMicrosoft 365OutlookMicrosoft 365 Apps & ServicesMicrosoft Email ProvidersAruba DNSApple School Manager
- Sector
- Research
- Industry code
- NAICS 541714, 325414, SIC 8731, 2836
- Region
- Toscana
Research in Italy
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Contraria Biotech in front of investors. Or tell us what we have wrong.